New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas by Marie Donzel, Lucile Baseggio, Juliette Fontaine, Florian Pesce, Hervé Ghesquières, Emmanuel Bachy, Aurélie Verney, Alexandra Traverse-Glehen

Get full text

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma by Lars P. Jordheim, Vincent Ribrag, Hervé Ghesquieres, Sophie Pallardy, Richard Delarue, Hervé Tilly, Corinne Haioun, Fabrice Jardin, Delphine Demangel, Gilles A. Salles, Charles Dumontet

Get full text

A Simple-to-Perform ifn-γ mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem... by Mathilde Boccard, Mathilde Boccard, Anne Conrad, Anne Conrad, William Mouton, William Mouton, Florent Valour, Florent Valour, Chantal Roure-Sobas, Emilie Frobert, Emilie Frobert, Barbara Rohmer, Vincent Alcazer, Vincent Alcazer, Hélène Labussière-Wallet, Hervé Ghesquières, Hervé Ghesquières, Fabienne Venet, Fabienne Venet, Fabienne Venet, Fabienne Venet, Karen Brengel-Pesce, Sophie Trouillet-Assant, Sophie Trouillet-Assant, Florence Ader, Florence Ader

Get full text

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for... by Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain

Get full text

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagn... by Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain

Get full text

Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraoc... by Carole Soussain, Sylvain Choquet, Emmanuelle Fourme, Daniel Delgadillo, Krimo Bouabdallah, Hervé Ghesquières, Gandhi Damaj, Brigitte Dupriez, Jacques Vargaftig, Alberto Gonzalez, Caroline Houillier, Luc Taillandier, Khê Hoang-Xuan, Véronique Leblond

Get full text

Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas by Wendy Revailler, Anne Ségolène Cottereau, Cedric Rossi, Rudy Noyelle, Thomas Trouillard, Franck Morschhauser, Olivier Casasnovas, Catherine Thieblemont, Steven Le Gouill, Marc André, Herve Ghesquieres, Romain Ricci, Michel Meignan, Salim Kanoun

Get full text

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case re... by Gandhi Damaj, Sarah Ivanoff, Diane Coso, Loïc Ysaebert, Sylvain Choquet, Caroline Houillier, Anne Parcelier, Wajed Abarah, Zora Marjanovic, Rémy Gressin, Reda Garidi, Momar Diouf, Anne-Claire Gac, Jehan Dupuis, Xavier Troussard, Franck Morschhauseur, Hervé Ghesquières, Carole Soussain

Get full text

Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects. by Juliette Périchou, Florence Ranchon, Chloé Herledan, Laure Huot, Virginie Larbre, Isabelle Carpentier, Anne Lazareth, Lionel Karlin, Karen Beny, Nicolas Vantard, Vérane Schwiertz, Anne Gaelle Caffin, Amandine Baudouin, Pierre Sesques, Gabriel Brisou, Hervé Ghesquières, Gilles Salles, Catherine Rioufol

Get full text

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy by Pierre Sesques, Lionel Karlin, Emmanuel Massy, Alizée Maarek, Guillaume Aussedat, Anne Lazareth, Camille Golfier, Fadhela Bouafia-Sauvy, Helene Lequeu, Dana Ghergus, Violaine Safar, Emmanuelle Ferrant, Emmanuel Bachy, Hervé Ghesquières, Cyrille B. Confavreux, Delphine Demangel, Emeline Perrial, Charles Dumontet

Get full text

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study by Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony Hatswell, Long Ma, Eve H. Limbrick-Oldfield, Julia Thornton Snider, Sally W. Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John Gribben

Get full text

P636: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES by Michal Kwiatek, Guru Subramanian Guru Murthy, Marc Hoffmann, Lindsey Roeker, Benoit Tessoulin, Alexey Danilov, Alvaro J. Alencar, Nirav N. Shah, Herve Ghesquieres, Steven Le Gouill, Wojciech Jurczak, Anthony R. Mato, Vishalkumar Patel, Yingying Guo-Avrutin, James M. Pauff, Maciej Kazmierczak

Get full text

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA by Olivier Fitoussi, Karim Belhadj, Nicolas Mounier, Marie Parrens, Hervé Tilly, Gilles Salles, Pierre Feugier, Christophe Ferme, Loic Ysebaert, Jean Gabarre, Raoul Herbrecht, Maud Janvier, Eric Van Den Neste, Franck Morschhauser, Olivier Casasnovas, Hervé Ghesquieres, Bruno Anglaret, Sabine Brechignac, Corinne Haioun, Christian Gisselbrecht

Get full text

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY. by Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, Vincent Ribrag, Rene Olivier Casasnovas, Corinne Haioun, Roch Houot, Fabrice Jardin, Eric Van Den Neste, Morgane Cheminant, Franck Morschhauser, Mary Callanan, Herve Ghesquieres, Remy Gressin, Olivier Hermine, Steven Le Gouill

Get full text

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association by Clémentine Sarkozy, Thierry Molina, Hervé Ghesquières, Anne-Sophie Michallet, Jehan Dupuis, Diane Damotte, Franck Morsschauser, Marie Parrens, Laurent Martin, Peggy Dartigues, Aspasia Stamatoullas, Pierre Hirsch, Bettina Fabiani, Krimo Bouabdallah, Maria Gomes da Silva, Marie Maerevoet, Camille Laurent, Bertrand Coiffier, Gilles Salles, Alexandra Traverse-Glehen

Get full text

A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma by Eric Van Den Neste, Marc André, Thomas Gastinne, Aspasia Stamatoullas, Corinne Haioun, Amine Belhabri, Oumedaly Reman, Olivier Casasnovas, Hervé Ghesquieres, Gregor Verhoef, Marie-José Claessen, Hélène A. Poirel, Marie-Christine Copin, Romain Dubois, Peter Vandenberghe, Ioanna-Andrea Stoian, Anne S. Cottereau, Sarah Bailly, Laurent Knoops, Franck Morschhauser

Get full text

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies by Aurélie Cabannes‐Hamy, Frederic Peyrade, Fabrice Jardin, Jean‐François Emile, Vincent Delwail, Nicolas Mounier, Corinne Haioun, Aurore Perrot, Olivier Fitoussi, Diane Lara, Richard Delarue, Marc André, Fritz Offner, Hervé Ghesquières, Laurent Pascal, Carole Soussain, Julien Lazarovici, Jean‐Marc Schiano, Philippe Gaulard, Hervé Tilly, Catherine Thieblemont, the LYSA, the lymphoma study association

Get full text

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline by Cédric Rossi, Marc André, Jehan Dupuis, Franck Morschhauser, Bertrand Joly, Julien Lazarovici, Hervé Ghesquières, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Anne-Claire Gac, Hannah Moatti, Luc-Matthieu Fornecker, Bénédicte Deau, Clémentine Joubert, Catherine Fortpied, John Raemaekers, Massimo Federico, Salim Kanoun, Michel Meignan, Alexandra Traverse-Glehen, Anne-Ségolène Cottereau, René-Olivier Casasnova

Get full text

P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE... by Wojciech Jurczak, Herve Ghesquieres, Yasmin Karimi, Chan Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, David Lewis, Robin Gasiorowski, Tae Min Kim, Marjolein Van Der Poel, Michelle Limei Poon, Tatyana Feldman, Kim Linton, Anna Sureda, Martin Hutchings, Salim Kanoun, Laetitia Vercellino, Mariana Cota Stirner, Stephanie Mcgoldrick, Yan Liu, Mariana Sacchi, Pieternella Lugtenburg, Catherine Thieblemont

Get full text

A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol o... by Hervé Ghesquières, Cédric Rossi, Fanny Cherblanc, Sandra Le Guyader-Peyrou, Fontanet Bijou, Pierre Sujobert, Pascale Fabbro-Peray, Adeline Bernier, Aurélien Belot, Loic Chartier, Luc-Matthieu Fornecker, Isabelle Baldi, Krimo Bouabdallah, Camille Laurent, Lucie Oberic, Nadine Morineau, Steven Le Gouill, Franck Morschhauser, Corinne Haioun, Gandhi Damaj, Stéphanie Guidez, Gaëlle Labouré, Olivier Fitoussi, Laure Lebras, Rémy Gressin, Gilles Salles, Loïc Ysebaert, Alain Monnereau

Get full text